Celltrion Investor Relations Material
Latest events
Investor Day 2024
Celltrion
Q2 2025
6 Aug, 2025
Q1 2025
9 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Celltrion Inc
Access all reports
Celltrion Inc. is a South Korea-based biotechnology company specializing in the research, development, and manufacturing of biopharmaceuticals. The company focuses on monoclonal antibodies, biosimilars, and innovative biologic therapies for various medical conditions. Celltrion operates state-of-the-art biopharmaceutical production facilities and engages in global partnerships for the commercialization of its products. The company is headquartered in Incheon, South Korea, and its shares are listed on the KRX.
Key slides for Celltrion Inc
Investor Presentation
Celltrion Inc
Investor Presentation
Celltrion Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
A068270
Country
🇰🇷 South Korea